Detalhe da pesquisa
1.
A multiparametric risk table for loss of clinical remission status in patients with rheumatoid arthritis: A starter study post-hoc analysis.
Rheumatology (Oxford)
; 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38364299
2.
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs.
Clin Exp Rheumatol
; 42(1): 104-114, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37650298
3.
B-Cell Activation Biomarkers in Salivary Glands Are Related to Lymphomagenesis in Primary Sjögren's Disease: A Pilot Monocentric Exploratory Study.
Int J Mol Sci
; 25(6)2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38542233
4.
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study.
Ann Rheum Dis
; 82(4): 496-506, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36600178
5.
Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data.
Rheumatology (Oxford)
; 62(10): 3382-3390, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810788
6.
COVID-19 illness: Different comorbidities may require different immunological therapeutic targets.
Eur J Clin Invest
; 53(12): e14096, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37724937
7.
Epeleuton, a novel synthetic ω-3 fatty acid, reduces the hypoxia/reperfusion stress in a mouse model of sickle cell disease.
Haematologica
; 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38105727
8.
Italian recommendations for the assessment of cardiovascular risk in rheumatoid arthritis: a position paper of the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group of the Italian Society for Rheumatology.
Clin Exp Rheumatol
; 41(9): 1784-1791, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36912349
9.
Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohort.
Clin Exp Rheumatol
; 41(3): 735-743, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36226614
10.
The measurement of fibromyalgia severity: converting scores between the FIQR, the PSD and the FASmod.
Clin Exp Rheumatol
; 41(6): 1225-1229, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36067219
11.
Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia: a registry-based study.
Clin Exp Rheumatol
; 41(6): 1275-1282, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37140611
12.
Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients.
Kidney Blood Press Res
; 48(1): 728-737, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37939680
13.
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19.
Int J Mol Sci
; 24(7)2023 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37047594
14.
Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial.
Int J Mol Sci
; 24(6)2023 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36982151
15.
Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio Study.
Ann Rheum Dis
; 81(6): 823-830, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35210262
16.
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response.
Rheumatology (Oxford)
; 61(9): 3799-3807, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34940840
17.
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study.
Clin Exp Rheumatol
; 40(5): 1019-1024, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34494955
18.
Fibromyalgia severity according to age categories: results of a cross-sectional study from a large national database.
Clin Exp Rheumatol
; 40(6): 1084-1090, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35383567
19.
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry.
Clin Exp Rheumatol
; 40(6): 1183-1188, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35748718
20.
Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results.
Ann Rheum Dis
; 80(11): 1419-1428, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34162594